| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 6182794 | Gynecologic Oncology | 2014 | 5 Pages |
Abstract
The AGO score could identify suitable candidates for secondary cytoreductive surgery but failed to prove an independent prognostic value thus suggesting an effect of successful surgery on its own. However, the latter has to be proven prospectively. In addition, further studies should evaluate the predictive and prognostic impact of a negative score.
Related Topics
Health Sciences
Medicine and Dentistry
Obstetrics, Gynecology and Women's Health
Authors
Philipp Harter, Bianca Beutel, Piero F. Alesina, Dietmar Lorenz, Andre Boergers, Florian Heitz, Rita Hils, Christian Kurzeder, Alexander Traut, Andreas du Bois,